| Product Code: ETC11477842 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Cancer Genome Sequencing Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Cancer Genome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Cancer Genome Sequencing Market - Industry Life Cycle |
3.4 Japan Cancer Genome Sequencing Market - Porter's Five Forces |
3.5 Japan Cancer Genome Sequencing Market Revenues & Volume Share, By Sequencing Type, 2021 & 2031F |
3.6 Japan Cancer Genome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Cancer Genome Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Cancer Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Japan Cancer Genome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in genome sequencing techniques |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for genome sequencing |
4.3.2 High costs associated with genome sequencing procedures |
4.3.3 Limited reimbursement policies for genome sequencing in Japan |
5 Japan Cancer Genome Sequencing Market Trends |
6 Japan Cancer Genome Sequencing Market, By Types |
6.1 Japan Cancer Genome Sequencing Market, By Sequencing Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Cancer Genome Sequencing Market Revenues & Volume, By Sequencing Type, 2021 - 2031F |
6.1.3 Japan Cancer Genome Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.1.4 Japan Cancer Genome Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021 - 2031F |
6.2 Japan Cancer Genome Sequencing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Cancer Genome Sequencing Market Revenues & Volume, By Oncology Research, 2021 - 2031F |
6.2.3 Japan Cancer Genome Sequencing Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.3 Japan Cancer Genome Sequencing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Cancer Genome Sequencing Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.3 Japan Cancer Genome Sequencing Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4 Japan Cancer Genome Sequencing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Japan Cancer Genome Sequencing Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.4.3 Japan Cancer Genome Sequencing Market Revenues & Volume, By Sanger Sequencing, 2021 - 2031F |
7 Japan Cancer Genome Sequencing Market Import-Export Trade Statistics |
7.1 Japan Cancer Genome Sequencing Market Export to Major Countries |
7.2 Japan Cancer Genome Sequencing Market Imports from Major Countries |
8 Japan Cancer Genome Sequencing Market Key Performance Indicators |
8.1 Adoption rate of next-generation sequencing (NGS) technologies in cancer diagnosis and treatment |
8.2 Number of collaborations between research institutions, biotech companies, and healthcare providers for genome sequencing projects |
8.3 Rate of integration of genomic data into clinical decision-making processes in oncology practice |
9 Japan Cancer Genome Sequencing Market - Opportunity Assessment |
9.1 Japan Cancer Genome Sequencing Market Opportunity Assessment, By Sequencing Type, 2021 & 2031F |
9.2 Japan Cancer Genome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Cancer Genome Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Cancer Genome Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Japan Cancer Genome Sequencing Market - Competitive Landscape |
10.1 Japan Cancer Genome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Japan Cancer Genome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here